Muvon Therapeutics
Phase 1MUVON Therapeutics is a Biotech Spin-off from the University of Zurich with the goal of developing and commercializing a novel therapy for the regeneration of skeletal muscle tissue based on autologous cells. Our initial area of focus is developing a safe and effective treatment for stress urinary incontinence in women.
Founded
2018
Focus
Cell & Gene Therapy
About
MUVON Therapeutics is a Biotech Spin-off from the University of Zurich with the goal of developing and commercializing a novel therapy for the regeneration of skeletal muscle tissue based on autologous cells. Our initial area of focus is developing a safe and effective treatment for stress urinary incontinence in women.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationZurich, Switzerland
StagePhase 1
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile